CDN1163 alleviates SERCA2 dysfunction-induced pulmonary vascular remodeling by inhibiting the phenotypic transition of pulmonary artery smooth muscle cellsWeimin Yu, Xiaoyong Tong, Xiaoyang Huang et al.|Clinical and Experimental Hypertension|2023Cited by 9
SERCA2 dysfunction stimulates inflammation and causes pulmonary vascular remodeling by downregulating PPARγ/PGC1α/Nrf2Yixiang Qiu, Xiaoyong Tong, Hui Chen et al.|European Journal of Pharmacology|2025Cited by 1